Imagine an assay finishes at 10:00, but the result is released at 11:20. Buying a faster instrument would not remove the eighty minutes after the run.
That interval may contain necessary checks. It may also contain a failed transfer, an unassigned review, or a report waiting for release. Improving LIS report turnaround time starts by separating those activities instead of treating the entire delay as “laboratory processing.”
This guide focuses on the accession-to-release workflow in diagnostic laboratories. It explains how to measure the delay, identify the handoff causing it, and improve coordination without weakening result quality. Scispot's role is to connect and improve the agreed scientific and digital workflow alongside the LIS—not assume responsibility for every clinical-system function.
What Is LIS Report Turnaround Time?
LIS report turnaround time is the elapsed time between a defined starting event and a defined reporting event recorded in or connected to a laboratory information system. In this guide, the start is specimen accessioning and the end is authorized release of the report or result.
Other measures may start at order entry, collection, receipt, or assay initiation. Some end at verification, transmission, or confirmed delivery. Those are valid measures for different questions, but they should not be compared as though they describe the same interval.
For U.S. nonwaived laboratory testing, CLIA's test-report requirements address timely, accurate, and reliable transmission of results. They also address critical-result alerts and assessment of notification needs when established reporting time frames cannot be met. The rule does not establish one universal turnaround target for every test.
Where Diagnostic Reporting Slows Down
Look for the boundary where a completed activity waits to become someone else's actionable work.
Specimens may wait for accession details or acceptance decisions. Accepted samples may wait for assignment or a batch cutoff. Instrument results may wait for transfer, identity matching, or processing. Completed checks may wait for review. Approved output may wait for transmission or exception resolution.
These are different problems. Missing accession information calls for better intake and exception handling. Batch scheduling calls for capacity and service-level decisions. A failed interface calls for monitoring and ownership. A review queue calls for workload visibility and an appropriate routing process.
A single average turnaround number does not reveal which intervention is needed.
The Diagnostic Report Workflow From Accessioning to Result
The following stages describe a practical operating model. They are not a prescribed clinical SOP. Result checks and QC can be interdependent or occur earlier in the process; listing them separately does not permit releasing results before required controls are satisfied.
Step 1: Specimen accessioning
Create or confirm the specimen record, test request, identifiers, and relevant receipt information. Identify missing information and acceptance issues using the lab's procedure.
Keep specimen receipt and accession timestamps distinct when both matter. Otherwise, delayed data entry can make the measured accession-to-result workflow look faster than the actual laboratory experience.
Step 2: Test assignment and processing
Assign the required work and prepare the specimen as appropriate. Record priority, routing, and any external referral or batching condition that affects the promised service.
Measure waiting for assignment separately from active preparation where the available event data permits it.
Step 3: Assay execution and data generation
Link the specimen or derived preparation to its run, position, and source data. Capture the relevant start and completion events.
An instrument finishing a run is not the same as a report becoming ready. Preserve the distinction between physical assay completion, data arrival, and successful processing.
Step 4: Result validation
Here, result validation means the laboratory's defined technical verification of a particular result. It does not mean initial assay validation or validation of the computerized system.
The process may include confirming identity, units, calculations, flags, and completeness. Its requirements and permitted automation must be established for the specific test and intended use.
Step 5: QC and exception checks
Assess the controls and exceptions required by the laboratory procedure. Route unresolved conditions to an authorized owner.
A target time is not a reason to bypass a required check. For nonwaived testing, CLIA also requires corrective-action policies when the test system fails to meet established performance specifications.
Step 6: Report review
Present the appropriate reviewer with the result and relevant context. Make unresolved issues and the next owner visible.
Separate time waiting for review from active review when possible. A queue may need staffing or routing changes; a complex review may legitimately require more time.
Step 7: Approval and result release
Capture the required authorization and release the result through the agreed LIS or reporting process. Keep technical completion, authorized release, successful transmission, and any required recipient acknowledgment distinct.
Clinical critical-result communication must follow the laboratory's applicable obligations and procedures. It should not be reduced to an ordinary report-delivery notification. CLIA test-report requirements.
Common Causes of Long LIS Report Turnaround Times
- Incomplete intake. A specimen can be physically present but not ready for assigned work. Expose the missing information and its owner rather than hide it inside a generic accession status.
- Disconnected status. The LIS may show “in process” while a related instrument or workflow has completed its activity. The delay belongs to the handoff, not necessarily the assay.
- Inconsistent identifiers or units. Manual reconciliation can prevent results from reaching a review-ready state. Better data mapping may be more useful than faster report formatting.
- Batch and referral timing. Cutoffs, operating hours, and external laboratory dependencies affect the elapsed interval. Treat them as explicit service conditions rather than unexplained outliers.
- Unowned exceptions. A result waits because several teams can see the issue but nobody is accountable for resolving it.
- Release or interface failures. Approval may be complete while the destination has not received the report. Monitoring must extend to the endpoint used in the service commitment.
How to Measure Laboratory Report Turnaround Time
Start with an agreed event definition:
Accession-to-release TAT = authorized release timestamp − accession timestamp.
Record whether elapsed time is calendar time or a clearly defined business-time measure. Normalize time zones and verify that clocks and timestamp meanings are consistent across connected systems.
An illustrative diagnostic workflow clock
This Scispot editorial framework shows how to decompose one interval. The times are invented for explanation. They are not a clinical benchmark or a Scispot customer outcome.
In this example, 140 minutes occur outside assay execution. That does not mean all 140 minutes are waste. Some preparation, verification, and review are necessary. More detailed events are needed before assigning an improvement target.
Compare like with like
Stratify by test or panel, priority, site, referral status, and relevant service conditions. Do not compare a routine in-house assay with a referred test under one unqualified target.
Use a defined cohort. A completed-results dashboard can hide the oldest cases because unreleased work has no final TAT yet. Show open-work age alongside completed-report statistics.
If activities overlap, do not add their durations and call the sum end-to-end TAT. The elapsed interval and the decomposition must reconcile.
Key Metrics for Diagnostic Report Turnaround Time
Use a balanced set of measures rather than a single average.
Also inspect specimen rejection, repeat testing, and QC exceptions where relevant. Avoid combining them into a score that obscures the reason for delay. Report counts, denominators, exclusions, and time definitions beside the metrics.
How to Improve LIS Report Turnaround Time?
Remove one measured handoff first
Choose a repeated source of delay that can be changed without compromising clinical control. Examples include an instrument-to-record transfer, an identity-mapping step, a review assignment, or a failed-release notification.
Baseline the interval before changing it. Confirm that the event data is reliable enough to support the diagnosis.
Make data review-ready sooner
Automate defined transfers and checks where appropriate. Preserve source references and expose mismatched identifiers or incomplete inputs. Avoid making reviewers the default data-reconciliation team.
Give exceptions an accountable owner
A visible flag is only the beginning. Define the next action, escalation route, and authority needed to resolve it. Different urgency levels and exception types may need different processes.
Validate the change and track balancing measures
Assess intended use, interfaces, roles, and failure paths. Test representative data and retain the evidence required by the laboratory's quality process. Confirm that improved speed does not increase correction rates or unresolved quality issues.
Do not remove a necessary review step merely because it takes time. Establish why the step exists and which repetitive work can be removed around it.
How Scispot Can Help Improve LIS Report Turnaround Time
Scispot's AI-native lab transformation model is relevant when diagnostic reporting delay crosses systems: specimen or sample context, assay execution, instrument data, QC, review, and release handoffs. Its Digital Brain connects those operating relationships so teams can see and improve the agreed workflow.
The boundary is important. Scispot is not automatically a replacement for a hospital LIS, billing system, pathology workflow, patient-order system, or clinical communication process. The laboratory retains clinical authority, and the existing LIS can remain the authoritative reporting system.
Connect the handoff that is actually slow
GLUE describes connections among instruments, LIS, other lab systems, and data platforms. A focused workstream can define the specimen or sample mapping, required result fields, timestamps, and acknowledgments needed for one selected flow.
The engineering scope should include failed transfers and stale status, not only successful ingestion. A result cannot be considered ready merely because a file has arrived.
Combine scientific context with an operational view
A forward-deployed scientist helps distinguish necessary assay or review work from avoidable coordination. Engineers connect the agreed data and status events. The laboratory and Quality owners define which checks, approvals, and release responsibilities must remain.
Recommended outputs include a timestamp dictionary, an ownership map, a connected work queue, defined exception routes, and a TAT dashboard with balancing measures. These are proposed workstream deliverables, not claims that every LIS interface is prebuilt.
Adapt the workflow without forcing a new clinical system
Scispot can provide role-specific lab workspaces around the shared records while retaining useful systems. The analyst sees missing data; the reviewer sees work ready for review; the operations lead sees aged queues and failed handoffs.
Scispot combines that platform work with scientific and engineering delivery, training, and ongoing optimization. The engagement is organized around the outcome and scope rather than the number of users. Scispot delivery model
Use relevant proof without borrowing a benchmark
Scispot's published molecular diagnostics case describes connecting laboratory and business systems and adding structured data checks. That supports the integration-and-data-quality mechanism. It does not establish a measured accession-to-release TAT improvement, and should not be represented as one.
For your lab, proof should come from the selected workflow: fewer manual handoffs, shorter measured queue time, reliable release-status visibility, and stable quality measures. Quality retains regulated sign-off; AI assistance does not bypass it.
